μεθο 12.5
|
|
ων δϊψετδ αΰπβμιϊ: Lotan 12.5.
ξητωιν ϊψετδ ΰηψϊ? λπρε μΰιπγχρ δϊψετεϊ »
|
|
 αρμ δαψιΰεϊ
φεψϊ ξϊο
PER OS
ξιπεο
Tablets
ωιξεω αϊψετδ
Heart failure: Lotan 12.5 is indicated for the treatment of heart failure, when treatment with an ACE inhibitor is no longer considered appropriate. Switching patients with heart failure who are stable on an ACE inhibitor to Lotan 12.5 mg is not recommended
ξρτψ ψιωεν
137 93 31629 00
ιφψο
Trima Israel Pharmaceutical Products Maabarot Ltd, Israel
ϊεχσ ψιωιεο μϊψετδ
12/2013 - 11/2018
|
ηεξψ τςιμ
|
ψιλεζ / λξεϊ αιηιγϊ ξιπεο
|
| Losartan as potassium |
12.5 MG |
|
ΰψιζδ
|
λξεϊ αΰψιζδ
|
ηιι ξγσ
|
ϊψετϊ ξψων
|
| Blister pvc/aluminium |
5 x TABLETS |
ηεγωιν 36 |
λο |
| Blister pvc/aluminium |
7 x TABLETS |
ηεγωιν 36 |
λο |
| Blister pvc/aluminium |
10 x TABLETS |
ηεγωιν 36 |
λο |
| Blister pvc/aluminium |
14 x TABLETS |
ηεγωιν 36 |
λο |
| Blister pvc/aluminium |
15 x TABLETS |
ηεγωιν 36 |
λο |
| Blister pvc/aluminium |
20 x TABLETS |
ηεγωιν 36 |
λο |
| Blister pvc/aluminium |
28 x TABLETS |
ηεγωιν 36 |
λο |
| Blister pvc/aluminium |
30 x TABLETS |
ηεγωιν 36 |
λο |
|
|
|
|
